ENVERIC BIOSCIENCES, INC. Operating Lease Right-of-Use Assets
ENVERIC BIOSCIENCES, INC. (ENVB) had Operating Lease Right-of-Use Assets of $9.61 thousand as of 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-03-26
- 2023-06-30: Operating Lease, Right-of-Use Asset $9.61K.
- 2023-03-31: Operating Lease, Right-of-Use Asset $37.04K.
- 2022-12-31: Operating Lease, Right-of-Use Asset $63.82K.
- 2022-09-30: Operating Lease, Right-of-Use Asset $88.77K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2023-06-30 | $9.61K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $37.04K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $63.82K 10-K · filed 2024-03-26 | |
| 2022-09-30 | $88.77K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $120.97K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $151.32K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $176.30K 10-K/A · filed 2023-06-09 | |
| 2020-09-30 | $874.61K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $907.00K 10-Q · filed 2020-08-14 | |
| 2019-12-31 | $286.16K 10-Q · filed 2020-11-16 | $286.16K 10-K/A · filed 2020-08-12 |
| 2019-09-30 | $315.19K 10-K/A · filed 2020-08-12 | |
| 2019-06-30 | $343.71K 10-K/A · filed 2020-08-12 | |
| 2019-01-02 | $371.75K 10-K/A · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |